Absci Reports Second Quarter 2022 Financial Results and Business Update

Go back to Absci Reports Second Quarter 2022 Financial Results and Business Update

JPMorgan Double Downgrades Absci Corp. (ABSI) to Underweight

August 12, 2022 12:32 PM EDT

JPMorgan analyst Tycho Peterson downgraded Absci Corp. (NASDAQ: ABSI) from Overweight to Underweight.

The analyst comments "ABSI offers an integrated drug creation platform that leverages proprietary synthetic biology technologies and deep learning AI to enable efficient discovery and development of novel protein-based drugs. The... More